111 Capital Takes Position in Dolby Laboratories, Inc. (NYSE:DLB)

111 Capital acquired a new stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 8,180 shares of the electronics maker's stock, valued at approximately $639,000.

Other large investors also recently modified their holdings of the company. Fifth Third Bancorp grew its stake in shares of Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 163 shares during the period. Nisa Investment Advisors LLC grew its stake in shares of Dolby Laboratories by 436.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after purchasing an additional 301 shares during the period. Mather Group LLC. grew its stake in shares of Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after purchasing an additional 142 shares during the period. Headlands Technologies LLC bought a new stake in shares of Dolby Laboratories in the 4th quarter valued at approximately $57,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Dolby Laboratories in the 4th quarter valued at approximately $71,000. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Trading Down 0.5%

NYSE DLB traded down $0.35 during trading hours on Monday, reaching $73.91. 295,690 shares of the company's stock were exchanged, compared to its average volume of 452,652. The stock has a market cap of $7.10 billion, a PE ratio of 27.17 and a beta of 0.95. Dolby Laboratories, Inc. has a one year low of $66.35 and a one year high of $89.66. The firm has a fifty day moving average of $75.17 and a 200-day moving average of $78.64.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The electronics maker reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.29 by $0.05. Dolby Laboratories had a return on equity of 11.32% and a net margin of 19.97%. The firm had revenue of $369.56 million for the quarter, compared to the consensus estimate of $375.44 million. During the same quarter in the prior year, the business earned $1.27 EPS. The business's revenue for the quarter was up 1.4% compared to the same quarter last year. As a group, research analysts forecast that Dolby Laboratories, Inc. will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 21st. Shareholders of record on Tuesday, May 13th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.79%. The ex-dividend date of this dividend was Tuesday, May 13th. Dolby Laboratories's dividend payout ratio is 49.81%.

Wall Street Analysts Forecast Growth

DLB has been the topic of a number of research analyst reports. Barrington Research restated an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a research report on Friday, May 2nd. Wall Street Zen upgraded Dolby Laboratories from a "hold" rating to a "buy" rating in a research report on Friday. Rosenblatt Securities decreased their price target on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Finally, Tigress Financial initiated coverage on Dolby Laboratories in a research report on Thursday, May 15th. They set a "buy" rating and a $112.00 price target on the stock.

Insiders Place Their Bets

In other news, SVP John D. Couling sold 675 shares of the stock in a transaction on Monday, May 5th. The stock was sold at an average price of $75.04, for a total value of $50,652.00. Following the transaction, the senior vice president now owns 121,151 shares of the company's stock, valued at $9,091,171.04. This represents a 0.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 38.39% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.